↑↓ navigate open esc close
Czech Republic NEN contract award · ocds-ted-276972-2025

Czechia – Immunosuppressive agents – Selektivní imunosupresiva - Risankizumab I.

Institut klinické a experimentální medicíny awarded Kč18.1M to Alliance Healthcare s.r.o. for Professional Services & Consulting in April 2025 — one of 690 awards this buyer has made, above its typical award size.

29 Apr 2025
Award date
Kč18.1M
Contract value
690 Awards
Kč9.9M Avg award
Above vs typical

Winning supplier

Alliance Healthcare s.r.o.
71 Awards
31 Buyers
Kč1.9B Total won

Contract description

Czechia – Immunosuppressive agents – Selektivní imunosupresiva - Risankizumab I.

Premium

Related awards · Institut klinické a experimentální medicíny

690 awards

The buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.

Full dataset

Unlock the full data.

Subscribe to reveal every row, year-over-year trends, and CSV / API export.

Unlock full dataset →

646 more awards from this buyer · full history & CSV export

Premium

Other wins · Alliance Healthcare s.r.o.

71 wins

The supplier's complete win history across every buyer it sells to — not just the handful shown here.

Locked rows — unlock the full dataset below.

Premium · full dataset

See the full award context.

Competing bids, award margins and every related contract for Institut klinické a experimentální medicíny and Alliance Healthcare s.r.o. — one subscription unlocks everything.

Sign Up Free →

Free account · cancel anytime · 14-day money-back

Sign Up